has anyone died from compounded semaglutide Off-Label Linked to Deaths, Hospitalizations Calling for Compounding Regulation Weight-loss drug tied to lower
Description
Federal regulators have also begun to increase enforcement actions against companies promoting compounded GLP-1 drugs with misleading claims about safety and equivalence to approved medicines
In adults, the focus is predominantly on reversing weight regain and improving cardiometabolic parameters
Diabetes Treatment Originally, semaglutide was developed to treat Type 2 diabetes
Many GLP-1 med spa programs focus primarily on providing weight loss medications and may offer varying levels of medical oversight
J.F., Harte, S.E., Elliott, J.M., Kessler, R.C., Koenen, K.C., McLean, S.A., Nickerson, L.D., Ressler, K.J., Stevens, J.S
